Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

University of Pittsburgh Cancer Institute, Pittsburgh

University of Maryland/Greenebaum Cancer Center, Baltimore

Northern Indiana Cancer Research Consortium, South Bend

Fort Wayne Medical Oncology and Hematology Inc-Parkview, Fort Wayne

Oncology Care Associates PLLC, Saint Joseph

Medical College of Wisconsin, Milwaukee

Loyola University Medical Center, Maywood

Evanston Hospital CCOP, Evanston

Ingalls Memorial Hospital, Harvey

Joliet Oncology-Hematology Associates Limited, Joliet

University of Chicago, Chicago

Central Illinois Hematology Oncology Center, Springfield

Peoria Gynecologic Oncology, Peoria

Decatur Memorial Hospital, Decatur

Saint John's Mercy Medical Center, St Louis

University of Southern California/Norris Cancer Center, Los Angeles

City of Hope, Duarte

City of Hope Medical Group Inc, Pasadena

University of California at Davis Cancer Center, Sacramento

Oncology/Hematology Associates, Peoria

University of Michigan Comprehensive Cancer Center, Ann Arbor

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston

London Health Sciences Centre-South Street, London

London Regional Cancer Program, London

The Ottawa Hospital Cancer Centre (Ottawa Health Research Institute) Civic Campus, Ottawa

University Health Network-Princess Margaret Hospital, Toronto

CHUM - Hopital Notre-Dame, Montreal